CDK7

(redirected from Cyclin-Dependent Kinase 7)
Also found in: Medical.
AcronymDefinition
CDK7Cyclin-Dependent Kinase 7 (human gene)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
SY-1365, a first-in-class selective cyclin-dependent kinase 7 inhibitor, is currently being investigated in a Phase 1 clinical trial as a single agent and in combination with standard-of-care therapies in multiple ovarian and breast cancer patient populations that lack effective treatment options.
SY-1365 is a first-in-class selective cyclin-dependent kinase 7 inhibitor with potential across a range of difficult-to-treat solid tumors and blood cancers.
Syros Pharmaceuticals announced that it will present new preclinical data on SY-1365, its first-in-class selective cyclin-dependent kinase 7 inhibitor currently in a Phase 1 clinical trial focused on ovarian and breast cancers, and on SY-5609, its selective oral CDK7 inhibitor that the company has named as its next development candidate, at the American Association for Cancer Research Annual Meeting taking place March 29-April 3 in Atlanta.
Full browser ?